Utilization Patterns of Amantadine in Parkinson’s Disease Patients Enrolled in the French COPARK Study-Reference-Cited by-同舟云学术

Utilization Patterns of Amantadine in Parkinson’s Disease Patients Enrolled in the French COPARK Study

Published:2020-01-10 Issue:3 Volume:37 Page:215-223
ISSN:1170-229X
Container-title:Drugs & Aging
language:en
Short-container-title:Drugs Aging

Author:

Rascol Olivier, ,Negre-Pages Laurence,Damier Philippe,Delval Arnaud,Derkinderen Pascal,Destée Alain,Fabbri Margherita,Meissner Wassilios G.,Rachdi Amine,Tison François,Perez-Lloret Santiago

Funder

Various Funders

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Geriatrics and Gerontology

Link

http://link.springer.com/content/pdf/10.1007/s40266-019-00740-2.pdf

Reference27 articles.

1. Schwab RS, England AC Jr, Poskanzer DC, et al. Amantadine in the treatment of Parkinson’s disease. JAMA. 1969;208:1168–70.

2. Perez-Lloret S, Rascol O. Efficacy and safety of amantadine for the treatment of L-DOPA-induced dyskinesia. J Neural Transm (Vienna). 2018;125:1237–50.

3. Chase TN, Oh JD. Striatal dopamine- and glutamate-mediated dysregulation in experimental parkinsonism. Trends Neurosci. 2000;23:S86–91.

4. Huot P, Johnston TH, Koprich JB, et al. The pharmacology of L-DOPA-induced dyskinesia in Parkinson’s disease. Pharmacol Rev. 2013;65:171–222.

5. Verhagen Metman L, Del Dotto P, Blanchet PJ, et al. Blockade of glutamatergic transmission as treatment for dyskinesias and motor fluctuations in Parkinson’s disease. Amino Acids. 1998;14:75–82.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Amantadine use in the French prospective NS-Park cohort;Journal of Neural Transmission;2024-04-05

2. A Machine-Learning-Based Method to Detect Degradation of Motor Control Stability with Implications to Diagnosis of Presymptomatic Parkinson’s Disease: A Simulation Study;Applied Sciences;2023-08-22

3. A Machine-learning-based Method to Detect Degradation of Motor Control Stability with Applications to Diagnosis of Presymptomatic Parkinson’s Disease;2022-10-20

4. An EGFP Knock-in Zebrafish Experimental Model Used in Evaluation of the Amantadine Drug Safety During Early Cardiogenesis;Frontiers in Cardiovascular Medicine;2022-04-05

5. Amantadine treatment and delayed onset of levodopa‐induced dyskinesia in patients with early Parkinson's disease;European Journal of Neurology;2022-01-10